Unicycive Therapeutics Inc (UNCY) is near the top in its industry group according to InvestorsObserver. UNCY gets an overall rating of 63. That means it scores higher than 63 percent of stocks. Unicycive Therapeutics Inc gets a 74 rank in the Biotechnology industry. Biotechnology is number 19 out of 148 industries.
UNCY has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on UNCY!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Unicycive Therapeutics Inc Stock Today?
Unicycive Therapeutics Inc (UNCY) stock is flat 0.2% while the S&P 500 is down -0.06% as of 1:18 PM on Wednesday, Mar 20. UNCY is flat $0.00 from the previous closing price of $1.39 on volume of 168,972 shares. Over the past year the S&P 500 is higher by 29.29% while UNCY is down -38.22%. UNCY lost -$1.75 per share the over the last 12 months.
Click Here to get the full Stock Report for Unicycive Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
